Weilin Peng

785 total citations
43 papers, 558 citations indexed

About

Weilin Peng is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Weilin Peng has authored 43 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Clinical Biochemistry and 12 papers in Cancer Research. Recurrent topics in Weilin Peng's work include Metabolism and Genetic Disorders (12 papers), Mitochondrial Function and Pathology (9 papers) and RNA modifications and cancer (8 papers). Weilin Peng is often cited by papers focused on Metabolism and Genetic Disorders (12 papers), Mitochondrial Function and Pathology (9 papers) and RNA modifications and cancer (8 papers). Weilin Peng collaborates with scholars based in China, Saudi Arabia and United States. Weilin Peng's co-authors include Genxi Li, Xinjian Liu, Murat Açar, Yi Xu, Ping Liu, Ruijie Song, Yiming Lin, Mingjiu Chen, Jie Deng and Boxue He and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Biosensors and Bioelectronics.

In The Last Decade

Weilin Peng

42 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weilin Peng China 15 341 107 74 73 71 43 558
Yihan Wang China 14 454 1.3× 49 0.5× 13 0.2× 98 1.3× 22 0.3× 33 640
Geppo Sartori Italy 17 786 2.3× 103 1.0× 60 0.8× 40 0.5× 4 0.1× 40 890
Salah Adlat China 13 252 0.7× 68 0.6× 26 0.4× 78 1.1× 25 0.4× 32 473
Ellen Rohde United States 12 257 0.8× 40 0.4× 46 0.6× 41 0.6× 18 0.3× 21 550
Zhan Qi China 15 275 0.8× 24 0.2× 85 1.1× 42 0.6× 4 0.1× 51 611
Paulin N. Wahjudi United States 7 445 1.3× 48 0.4× 24 0.3× 97 1.3× 9 0.1× 9 620
С. В. Никулин Russia 14 313 0.9× 28 0.3× 21 0.3× 180 2.5× 9 0.1× 61 608
Lixia Yang China 13 499 1.5× 14 0.1× 24 0.3× 375 5.1× 7 0.1× 38 837
Donghyun Lim South Korea 15 659 1.9× 22 0.2× 91 1.2× 63 0.9× 3 0.0× 38 928

Countries citing papers authored by Weilin Peng

Since Specialization
Citations

This map shows the geographic impact of Weilin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilin Peng more than expected).

Fields of papers citing papers by Weilin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilin Peng. The network helps show where Weilin Peng may publish in the future.

Co-authorship network of co-authors of Weilin Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Weilin Peng. A scholar is included among the top collaborators of Weilin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilin Peng. Weilin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Wenxiang, Weilin Peng, Qisheng Li, et al.. (2024). Fisetin orchestrates neuroinflammation resolution and facilitates spinal cord injury recovery through enhanced autophagy in pro-inflammatory glial cells. International Immunopharmacology. 130. 111738–111738. 13 indexed citations
2.
Li, Wei, Weilin Peng, Xinlin Liu, et al.. (2024). HDAC8 Enhances the Function of HIF‐2α by Deacetylating ETS1 to Decrease the Sensitivity of TKIs in ccRCC. Advanced Science. 11(36). e2401142–e2401142. 5 indexed citations
3.
Lin, Yiming, Zhenzhu Zheng, Weihua Lin, & Weilin Peng. (2024). Incorporating Next‐Generation Sequencing as a Second‐Tier Test for Primary Carnitine Deficiency. Molecular Genetics & Genomic Medicine. 12(9). 1 indexed citations
4.
Lin, Weihua, et al.. (2023). Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency. Clinica Chimica Acta. 552. 117617–117617. 4 indexed citations
5.
Peng, Weilin, Long Wen, Rong Jiang, Jie Deng, & Mingjiu Chen. (2023). CHAC2 promotes lung adenocarcinoma by regulating ROS-mediated MAPK pathway activation. Journal of Cancer. 14(8). 1309–1320. 6 indexed citations
6.
Cai, Qidong, Boxue He, Weilin Peng, et al.. (2023). Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma. iScience. 26(7). 107013–107013. 5 indexed citations
7.
Lin, Yiming, et al.. (2022). Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency. Clinica Chimica Acta. 537. 181–187. 4 indexed citations
8.
Yao, Jianfeng, et al.. (2022). PTEN expression in human cumulus cells is associated with embryo development competence. Zygote. 30(5). 611–618. 5 indexed citations
9.
He, Boxue, Qidong Cai, Pengfei Zhang, et al.. (2022). Switched alternative splicing events as attractive features in lung squamous cell carcinoma. Cancer Cell International. 22(1). 5–5. 1 indexed citations
11.
Zhang, Pengfei, Boxue He, Qidong Cai, et al.. (2021). Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity. Frontiers in Oncology. 11. 705888–705888. 4 indexed citations
12.
Zhao, Zhenyu, Qidong Cai, Pengfei Zhang, et al.. (2021). N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis. Frontiers in Molecular Biosciences. 8. 657087–657087. 24 indexed citations
14.
Peng, Weilin, Qidong Cai, Zhenyu Zhao, et al.. (2021). Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma. PeerJ. 9. e11687–e11687. 6 indexed citations
15.
Lin, Yiming, Dongmei Chen, Weilin Peng, et al.. (2020). Newborn screening for isovaleric acidemia in Quanzhou, China. Clinica Chimica Acta. 509. 25–29. 8 indexed citations
16.
Liu, Ping, et al.. (2017). Noise reduction as an emergent property of single-cell aging. Nature Communications. 8(1). 680–680. 30 indexed citations
17.
Song, Ruijie, Weilin Peng, Ping Liu, & Murat Açar. (2015). A cell size- and cell cycle-aware stochastic model for predicting time-dynamic gene network activity in individual cells. BMC Systems Biology. 9(1). 91–91. 14 indexed citations
18.
Lin, Song, et al.. (2010). Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells. Kidney & Blood Pressure Research. 33(3). 186–192. 46 indexed citations
19.
Xu, Yi, Weilin Peng, Xinjian Liu, & Genxi Li. (2004). A new film for the fabrication of an unmediated H2O2 biosensor. Biosensors and Bioelectronics. 20(3). 533–537. 57 indexed citations
20.
Peng, Weilin, Xinjian Liu, Wenjun Zhang, & Genxi Li. (2003). An electrochemical investigation of effect of ATP on hemoglobin. Biophysical Chemistry. 106(3). 267–273. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026